Institutional investors purchased a net $4.8 million shares of OPK during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 21.85% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HOLLENCREST SECURITIES LLC Bought 157.3 Thousand shares of OPKO Health Inc
ALGERT GLOBAL LLC Bought 85.3 Thousand shares of OPKO Health Inc
CREATIVE PLANNING, INC. Bought 71.0 Thousand shares of OPKO Health Inc